|
|
PubMed-Transfer Factor double blind studies |
|
|
Abstracts on Studies Conducted with Transfer Factor from Bovine Colostrum |
|
|
Abstracts on the Obesity Virus |
Links to Independent Studies
|
|
Independent Study on Transfer Factor |
|
|
Independent Study on Fibromyalia using Transfer Factor and Product Info. |
|
|
Independent Study from The Institute of Longevity Medicine |
Abstracts and Studies in PDF
| Download Adobe Acrobat Reader |
 |
| MEDLINE Abstracts |
|
1. Activities and characteristics of transfer factors
2. Transfer factors: identification of conserved sequences in transfer factor
molecules.
3. Immunomodulatory therapy of epilepsy with transfer factor
4. Immunotherapy with transfer factor of recurrent herpes simplex type I.
5. Lessons from a pilot study of transfer factor in chronic fatigue syndrome.
6. Transfer factor with anti-EBV activity as an adjuvant therapy for
nasopharyngeal carcinoma: a pilot study.
7. Murine transfer factors: dose-response relationships and routes of
administration.
8. Utility of transfer factor to detect different bronchodilator responses in
patients with chronic obstructive pulmonary disease.
9. Comparative study of transfer factor and acyclovir in the treatment of herpes
zoster.
10. Transfer factor in chronic mucocutaneous candidiasis.
11. Transfer factor as an adjuvant to non-small cell lung cancer (NSCLC)
therapy.
12. The use of transfer factors in chronic fatigue syndrome: prospects and
problems.
13. In vitro studies during long-term oral administration of specific transfer
factor.
14. Orally administered HSV-specific transfer factor (TF) prevents genital or
labial herpes relapses.
15. Use of transfer factor for the treatment of recurrent non-bacterial female
cystitis (NBRC): a preliminary report.
16. Preliminary observations using HIV-specific transfer factor in AIDS.
17. Immunotherapy with transfer factor of recurrent herpes simplex type I.
18. A preliminary report on the use of transfer factor for treating stage D3
hormone-unresponsive metastatic prostate cancer.
19. The biological activity of the transfer factor induced by bacterial antigens
20. Human specific transfer factor to Staphylococcus aureus antigens
21. Use of transfer factor in allergic bronchial asthma
22. The usefulness of transfer factor in asthma associated with frequent
infections.
23. Transfer factor and possible applications in gynecology.
24. Transfer factor in restoration of cell mediated immunity in lung cancer
patients.
| Transfer Factor and Clinical Applications |
|
Discusses the role
of TH1, TH2 and their dominate states. In addition to clinical applications.
| Independent Bio-Assay Overview |
|
According to William Hennen, Ph.D., Vice President of
Research and Development at 4Life, "Each and every batch of Transfer Factor™ is
tested by an independent laboratory with established, documented credentials in
assessing for transfer factor activity. Very few laboratories have the
experience or credentials to assay for TF activity. We go to great lengths to
assure the quality of transfer factor in our product. This is the reason our
distributors are consistently having such great success with Transfer Factor™.
From infants to the elderly, reports keep coming in every day with results that
have matched or exceeded our every expectation. Transfer factor has nearly 50
years of research and over 3,000 clinical studies and scientific papers proving
its existence and effectiveness. Our licensed patent proved for the first time
that transfer factor exists in colostrum and that it can be successfully
extracted and assayed."
| Independent Study on Transfer Factor |
|
This latest study reports that 4Life Transfer Factor™ and Transfer Factor Plus™ "induced immune-based killing of K562 cancer cells at a level unprecedented in our experience or known in medical research," according to the director of the laboratory. 4Life Transfer Factor™ and Transfer Factor Plus™ were tested for their ability to increase Natural Killer Cell (NK) activity by killing live cancer cells. The test results showed that 4Life Transfer Factor™ boosted NK cell activity 103% above normal immune response without supplementation, or about two times higher than the next highest product. In addition, it was revealed that Transfer Factor Plus™ increased the NK cell 248% above normal immune response without supplementation, or about five times higher than any of the other previously tested products. The best of more than 200 other products tested showed an increase of only 48.6%.
| Medical Abstracts |
|
There were no difference in the responses that were related to the route of administration. We conclude that oral route of administration is efficacious and should be used when possible. We have also studied the effects of transfer factors on immune responses by recipients. The details of this research are presented in the paper by Dr. Alvarez-Thull.
